We are interested in the regulation of cell proliferation during development. We have been characterizing two mutants,
lin-19 and
lin-23, that exhibit hyperplasia of multiple tissues. When maternal product is present,
lin-19 or
lin-23 embryos develop normally. In
lin-23 mutants, all larval blast cells, with the exception of germ cells, produce extra cells.
lin-19 mutants develop normally through the L1 stage, but all later larval blast cells produce extra cells. In the absence of maternal product,
lin-19 and
lin-23 embryos arrest with many cells but no overt morphogenesis. Both
lin-23 and
lin-19 are expressed at their highest levels in embryos, with appreciable expression during larval stages, and little expression in adults. A
lin-23 transcriptional lacZ expression construct is transiently expressed in dividing tissues during larval development, consistent with a role in regulating the cell cycle. Sequence homology suggests that LIN-19 and LIN-23 work to modulate the cell cycle machinery by targeting key cell cycle regulators for destruction. LIN-19 is 28% identical to the S. cerevisiae cell cycle protein CDC53 (M. Goebl, pers. comm.). LIN-23 is homologous to the yeast protein CDC4. CDC53 and CDC4 interact with CDC34, a ubiquitin- conjugating enzyme, to target both positive and negative cell cycle regulators (G1 cyclin and cyclin kinase inhibitors) for degradation.
lin-19 is a member of a new multi-gene family in higher eukaryotes, with at least 5 human, 4 C. elegans, 1 rice, and 2 Arabidopsis members. We envision that this gene family evolved to target specific classes of cell cycle regulators, to effect either positive or negative control of the cell cycle.